Company Description
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.
The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services.
The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products.
The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016.
CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
| Country | United States |
| Founded | 2005 |
| IPO Date | Jul 2, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 99 |
| CEO | Kang-Huai Wang |
Contact Details
Address: 18805 Cox Avenue, Suite 250 Saratoga, California 95070 United States | |
| Phone | 408 624 1488 |
| Website | capsovision.com |
Stock Details
| Ticker Symbol | CV |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001378325 |
| CUSIP Number | 140935107 |
| ISIN Number | US1409351079 |
| Employer ID | 20-3369494 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Kang-Huai Wang | Co-Founder, President, Chief Executive Officer and Director |
| Douglas Atkinson | Senior Vice President of Global Sales |
| David Garcia | Compliance Officer, SVice President of Finance, Principal Financial and Accounting Officer |
| Helen Chau | Manager of Human Resources |
| Anna Krylova | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2026 | 424B3 | Prospectus |
| Apr 22, 2026 | EFFECT | Notice of Effectiveness |
| Apr 17, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Apr 15, 2026 | SCHEDULE 13G/A | Filing |
| Apr 7, 2026 | SCHEDULE 13G/A | Filing |
| Apr 3, 2026 | DRS | [Cover] Draft Registration Statement |
| Mar 26, 2026 | 10-K | Annual Report |
| Mar 26, 2026 | 8-K | Current Report |
| Mar 20, 2026 | 8-K | Current Report |
| Mar 13, 2026 | 8-K | Current Report |